Innate Pharma Presents Preliminary P-II (TELLOMAK) Trial Results of Lacutamab for the Treatment of Advanced Mycosis Fungoides
Shots: The company reported the preliminary results from an ongoing P-II (TELLOMAK...
Ionis Provides Updates of ION449 in P-IIb (SOLANO) Study for the Treatment of Hypercholesterolemia
Shots: The P-IIb (SOLANO) study evaluates the efficacy, safety, and tolerability o...
Vir Biotechnology Reports the First Patient Dosing in the P-II (SOLSTICE) Trial of VIR-2218 and VIR-3434 for Chronic Hepatitis D V...
Shots: The first patient has been dosed in the P-II (SOLSTICE) trial evaluating th...
Novo Nordisk Presents P-IIIa (ONWARDS 2) Trial Results of Insulin Icodec for the Treatment of Type 2 Diabetes at EASD 2022
Shots: The P-IIIa (ONWARDS 2) trial evaluating insulin icodec (qw) vs insulin degl...
Biogen Publishes P-III (VALOR) Study Results of Tofersen for the Treatment of Amyotrophic Lateral Sclerosis at NEJM
Shots: The company reported the results from the P-III (VALOR) study in 108 patien...
Sanofi and Regeneron Published P-III Trial Results of Dupixent (dupilumab) for Atopic Dermatitis in The Lancet
Shots: The P-III trial evaluating the efficacy & safety of Dupixent added to S...
